Section Arrow
HOWL.NASDAQ
- Werewolf Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2026/04/14 23:10 EDT
Regular Hours
Last
 0.9175
-0.0001 (-0.01%)
Day High 
0.9631 
Prev. Close
0.9176 
1-M High
1.14 
Volume 
120.63K 
Bid
0.8992
Ask
0.96
Day Low
0.9063 
Open
0.9366 
1-M Low
0.7541 
Market Cap 
44.59M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.93 
20-SMA 0.87 
50-SMA 0.75 
52-W High 2.38 
52-W Low 0.5301 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.33/-0.99
Enterprise Value
52.28M
Balance Sheet
Book Value Per Share
0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HOTHHoth Therapeutics0.6459+0.134+26.18%-- 
ALLOAllogene Therapeutics2.28-0.78-25.49%-- 
VRAXVirax Biolabs Group Limited0.148-0.0184-11.06%-- 
CMNDClearmind Medicine Inc.0.91-0.52-36.36%-- 
REPLReplimune Group1.95+0.25+14.71%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.